Integer Holdings Corporation Securities Fraud Class Action Result of Overstated Demand and 32% Stock Decline - Investors may Contact Lewis...

F5, Inc. Securities Fraud Class Action Result of Data Breach and 24% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick ...

NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION

BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline - Investors may Contact Lewis Kahn, Esq...

NEUBERGER ENERGY INFRASTRUCTURE AND INCOME FUND ANNOUNCES MONTHLY DISTRIBUTION

Sciaticyl Product Information Updated as Consumer Interest in Nerve Pain Supplement Options Grows in 2026

NEUBERGER NEXT GENERATION CONNECTIVITY FUND ANNOUNCES MONTHLY DISTRIBUTION

DIANE WARREN IS RELENTLESS ABOUT MUSIC EDUCATION: Honored Alongside Shining Stars

Agreement Reached on Loan for Bay Area Transit Agencies

NativePath Native Hydrate Product Information Updated as Consumer Interest in Electrolyte and Amino Acid Supplement Options Grows in 2026

California Trim Clinic Reports Strong Nationwide Demand for Physician-Led Teen Medical Weight Management Program via Telemedicine

NativePath Collagen Peptides Product Information Updated as Consumer Interest in Collagen Supplement Options Grows in 2026

Apollo Neuroscience Announces 2025 Year in Review

NativePath Native Synbiotic Product Information Updated as Consumer Interest in Gut Health Supplement Options Grows in 2026

NativePath Native Creatine Product Information Updated as Consumer Interest in Muscle Support Supplement Options Grows in 2026

Employment & Labor Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, File Suit Against Xytech Systems, LLC, for Alleged...

NativePath Bladder Health Product Information Updated as Consumer Interest in Bladder Support Supplement Options Grows in 2026

SPACE FOR HUMANITY STATEMENT ON BLUE ORIGIN PAUSE OF NEW SHEPARD PROGRAM

Poriferous, LLC Granted U.S. Patent for Porous Polyethylene One Piece Ears

TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., Robbins Geller Rudman & Dowd LLP Encourages Investors and Potential...